Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?

Bulevirtide is a novel antiviral agent approved for suppression of chronic hepatitis D but requiring further research into optimising the treatment scheme.Aim. Comparative assessment of bulevirtide monotherapy versus combined treatment with bulevirtide and pegylat-ed interferon (PEG-IFN) using publi...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. E. Syutkin, A. O. Bueverov, P. O. Bogomolov
Format:	Article
Language:	Russian
Published:	Gastro LLC 2020-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	hepatitis d virus chronic hepatitis d bulevirtide pegylated interferon
Online Access:	https://www.gastro-j.ru/jour/article/view/489
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Current Views of Torque Teno Virus (TTV) in Liver Diseases
by: I. V. Maev, et al.
Published: (2020-09-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Knowledge, attitudes and practices to hepatitis B among South African primary healthcare staff
by: Atlegang Mashilo, et al.
Published: (2025-01-01)

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
by: M. V. Mayevskaya
Published: (2011-06-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case)
by: A. O. Bueverov, et al.
Published: (2010-02-01)

Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
by: A. O. Bueverov, et al.
Published: (2024-03-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Acute hepatitis of non-specified etiology
by: Ye. V. Tsyganova, et al.
Published: (2011-02-01)

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
by: V. T. Ivashkin, et al.
Published: (2014-07-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

The role of new hepatitis B vaccines in South Africa
by: G U van Zyl, et al.
Published: (2024-02-01)

Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection
by: K. R. Dudina, et al.
Published: (2011-06-01)

Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
by: Huang Chengrong, et al.
Published: (2025-02-01)

Positive hepatitis B surface antigen leads to a decrease in ovarian reserve in infertile patients receiving first in vitro fertilization treatment
by: Yutao Li, et al.
Published: (2025-02-01)

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01)

Global progress, challenges and strategies in eliminating public threat of viral hepatitis
by: Sihui Zhang, et al.
Published: (2025-02-01)

Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01)

The role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in patients with compensated liver cirrhosis
by: Reem M. Sabry, et al.
Published: (2025-02-01)

Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01)

Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01)

Epidemiological Study of Hepatitis B, C and HIV Cases among the Foreigners Visiting Sulaimani City from 2013 Through 2016
by: Mohammed Omer Mohammed, et al.
Published: (2019-10-01)

Knowledge of Healthcare Professionals Regarding Hepatitis B in Rania Hospitals
by: Zhino Raouf Ali, et al.
Published: (2020-12-01)

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
by: Guanghui Ren, et al.
Published: (2025-02-01)

Bioactive Compounds in Herbal Bitter Drinks and Effects on selected Hepatic Biomarkers in Albino Wister Rats in Lagos, Nigeria
by: A.B. Ojekale, et al.
Published: (2020-01-01)

Markers of chronic hepatitis B at patients with HIV-infection and treatment approaches
by: S. I. Maksimov, et al.
Published: (2010-11-01)

Role of alpha-fetoprotein in complex diagnostics of progressing course of chronic hepatitis B and C
by: I. A. Belavina, et al.
Published: (2012-06-01)

QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
by: Christian Labenz, et al.
Published: (2025-03-01)

Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01)